Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Didem Çakirsoy"'
Autor:
Raife Dilek Turan, Cihan Tastan, Derya Dilek Kancagi, Bulut Yurtsever, Gozde Sir Karakus, Samed Ozer, Selen Abanuz, Didem Cakirsoy, Gamze Tumentemur, Sevda Demir, Utku Seyis, Recai Kuzay, Muhammer Elek, Miyase Ezgi Kocaoglu, Gurcan Ertop, Serap Arbak, Merve Acikel Elmas, Cansu Hemsinlioglu, Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Cavit Kerem Kayhan, Fatma Tokat, Gurler Akpinar, Murat Kasap, Ayse Sesin Kocagoz, Ugur Ozbek, Dilek Telci, Fikrettin Sahin, Koray Yalcin, Siret Ratip, Umit Ince, Ercument Ovali
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract The SARS-CoV-2 virus caused the most severe pandemic around the world, and vaccine development for urgent use became a crucial issue. Inactivated virus formulated vaccines such as Hepatitis A and smallpox proved to be reliable approaches for
Externí odkaz:
https://doaj.org/article/0080510c27ab4fa68a13783ab005d11d
Autor:
Gozde Sir Karakus, Cihan Tastan, Derya Dilek Kancagi, Bulut Yurtsever, Gamze Tumentemur, Sevda Demir, Raife Dilek Turan, Selen Abanuz, Didem Cakirsoy, Utku Seyis, Samed Ozer, Omer Elibol, Muhammer Elek, Gurcan Ertop, Serap Arbak, Merve Acikel Elmas, Cansu Hemsinlioglu, Ayse Sesin Kocagoz, Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Ugur Ozbek, Dilek Telci, Fikrettin Sahin, Koray Yalcin, Siret Ratip, Ercument Ovali
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-19 (2021)
Abstract COVID-19 outbreak caused by SARS-CoV-2 created an unprecedented health crisis since there is no vaccine for this novel virus. Therefore, SARS-CoV-2 vaccines have become crucial for reducing morbidity and mortality. In this study, in vitro an
Externí odkaz:
https://doaj.org/article/46a25aaed32541e28966db05d0693f25
Autor:
Celal Alandağ, Derya Dilek Kancaği, Gözde Karakuş Sir, Didem Çakirsoy, Ercüment Ovali, Elanur Karaman, Elif Yüce, Feyyaz Özdemir
Publikováno v:
Revista da Associação Médica Brasileira v.68 n.8 2022
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Volume: 68, Issue: 8, Pages: 1023-1026, Published: 19 SEP 2022
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Volume: 68, Issue: 8, Pages: 1023-1026, Published: 19 SEP 2022
SUMMARY OBJECTIVES: Black cumin is widely used as a spice and as a traditional treatment. The active ingredient in black cumin seeds is thymoquinone. Thymoquinone has shown anticancer effects in some cancers. We planned to investigate its anticancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0cdb18ddb24e443eaa6ac2e1cc9b254
https://doi.org/10.1590/1806-9282.20220066
https://doi.org/10.1590/1806-9282.20220066
Autor:
Cansu Hemşinlioğlu, Elif Sibel Aslan, Cihan Tastan, Didem Çakırsoy, Raife Dilek Turan, Utku Seyis, Muhammer Elek, Gözde Sır Karakuş, Ömür Selin Günaydın, Selen Abanuz, Derya Dilek Kançağı, Bulut Yurtsever, Koray Yalçın, Murat Kasap, Ercüment Ovalı
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 2, Pp 118-124 (2023)
Objective: Hemophilia A is an X-linked recessive bleeding disorder caused by a deficiency of plasma coagulation factor VIII (FVIII), and it accounts for about 80%-85% of all cases of hemophilia. Plasma-derived therapies or recombinant FVIII concentra
Externí odkaz:
https://doaj.org/article/c4d89b70bef242af9b222fa0e01cf281
Autor:
Ebru Erdoğan, Koray Yalçın, Cansu Hemşinlioğlu, Aslıhan Sezgin, Utku Seyis, Derya Dilek Kancağı, Cihan Taştan, Bulut Yurtsever, Raife Dilek Turan, Didem Çakırsoy, Selen Abanuz, Gözde Sır Karakuş, Muhammer Elek, Hüseyin Saffet Beköz, Ali İhsan Gemici, Deniz Sargın, Mutlu Arat, Burhan Ferhanoğlu, Ebru Pekgüç, Serdar Örnek, Deram Büyüktaş, Nur Birgen, Siret Ratip, Ercüment Ovalı
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 3, Pp 206-210 (2022)
Objective: Chimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial products regarding their affordability
Externí odkaz:
https://doaj.org/article/556bd673500c45ae8473e751960454e8
Autor:
Cihan Taştan, Derya Dilek Kançağı, Raife Dilek Turan, Bulut Yurtsever, Didem Çakırsoy, Selen Abanuz, Muhammet Yılancı, Utku Seyis, Samed Özer, Selin Mert, Cavit Kerem Kayhan, Fatma Tokat, Merve Açıkel Elmas, Selçuk Birdoğan, Serap Arbak, Koray Yalçın, Aslıhan Sezgin, Ebru Kızılkılıç, Cansu Hemşinlioğlu, Ümit İnce, Siret Ratip, Ercüment Ovalı
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 4, Pp 234-247 (2020)
Objective: Relapsed and refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) are the focus of studies on hematological cancers. Treatment of these malignancies has undergone recent transformation with the
Externí odkaz:
https://doaj.org/article/23ae462105714cc7b49d3f11c108d506